Cargando…
Preventive and therapeutic opportunities: targeting BAP1 and/or HMGB1 pathways to diminish the burden of mesothelioma
Mesothelioma is a cancer typically caused by asbestos. Mechanistically, asbestos carcinogenesis has been linked to the asbestos-induced release of HMGB1 from the nucleus to the cytoplasm, where HMGB1 promotes autophagy and cell survival, and to the extracellular space where HMGB1 promotes chronic in...
Autores principales: | Carbone, Michele, Minaai, Michael, Takinishi, Yasutaka, Pagano, Ian, Yang, Haining |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10599047/ https://www.ncbi.nlm.nih.gov/pubmed/37880686 http://dx.doi.org/10.1186/s12967-023-04614-5 |
Ejemplares similares
-
BAP1 is a novel regulator of HIF-1α
por: Bononi, Angela, et al.
Publicado: (2023) -
Germline BAP1 mutations predispose to malignant mesothelioma
por: Testa, Joseph R., et al.
Publicado: (2011) -
Inhibition of the spindle assembly checkpoint kinase Mps-1 as a novel therapeutic strategy in malignant mesothelioma
por: Szymiczek, Agata, et al.
Publicado: (2017) -
BAP1 cancer syndrome: malignant mesothelioma, uveal and cutaneous melanoma, and MBAITs
por: Carbone, Michele, et al.
Publicado: (2012) -
HMGB1 targeting by ethyl pyruvate suppresses malignant phenotype of human mesothelioma
por: Pellegrini, Laura, et al.
Publicado: (2017)